Merck & Co joins biosecurity vaccine facility coalition
Merck & Co has joined a coalition to build a vaccine facility which is capable of simultaneously manufacturing multiple products and can quickly switch in response to a crisis.
Archives for March 15, 2010
China to build ‘one of largest biologics CMOs in Asia’
The Chinese government is supporting a $100m (€73m) project to build a contract biologics production facility in Beijing, which, by some measures, would be the largest in Asia.
AstraZeneca to sell branded generics in deal with Torrent
AstraZeneca targets global generics market in license and supply deal with Indian manufacturer Torrent Pharma.
TetraQ installs tech to speed trial sample analysis
Australia-based CRO TetraQ is doubling throughput of trial samples, resulting in a 30 per cent time saving for clients, by installing a Spark Symbiosis system at its site in Brisbane.
Centralising ECG trial data can cut costs 40%, says ERT
E Research Technology (ERT) launches Centralised Cardiac Safety 2.0 (CCS 2.0) service for ECG data and says approach improves efficiency, cuts costs and helps sponsors reach database lock quicker than distributed model.
Sigma adds big name small molecules to portfolio in Pfizer deal
Drug researchers will have greater access to some top selling molecules, including currently patented compounds atorvastatin, sildenafil and celecoxib, thanks to Sigma Aldrich’s new bioactives deal with US drug major Pfizer.